
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Transparency Life Sciences announced the successful completion of its VISITOR clinical trial. VISITOR was designed to assess the feasibility and ease, along with the quality and integrity, of collecting research-grade clinical data directly from subjects in their homes or offices using the Transparency Virtual Trials digital study hub.The study demonstrated that participants were able to adapt to using telemedicine devices to capture data commonly collected in clinical trials.
Read more about the study






